Cigarette smoking accelerated brain aging and induced pre-alzheimer-like neuropathology in rats

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Ho, Yuen Shan ^a   Yang, Xifei ^d   Yeung, Sze Chun ^b   Chiu, Kin ^a   Lau, Chi Fai ^a   Tsang, Andrea Wing Ting ^a   Mak, Judith Choi Wo ^a,b   Chang, Raymond Chuen Chung ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d Shenzhen Entry exit Inspection and Quarantine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPSIN I; SYNAPTOPHYSIN; TAU PROTEIN; TUBULIN; MAPT PROTEIN, RAT; NERVE PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CYTOSKELETON; DENTATE GYRUS; DISEASE PREDISPOSITION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE; NERVE CELL PLASTICITY; NERVE FIBER TRANSPORT; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PASSIVE SMOKING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; RAT; SYNAPSE; ACETYLATION; AGING; ANIMAL; BRAIN; CHEMISTRY; DISEASE MODEL; HUMAN; METABOLISM; NERVE DEGENERATION; PATHOLOGY; PREMATURE AGING; SIGNAL TRANSDUCTION; SMOKING; SPRAGUE DAWLEY RAT;

RATTUS;

ACETYLATION; AGING; AGING, PREMATURE; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; NERVE DEGENERATION; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SMOKING; SYNAPSES; TAU PROTEINS; TOBACCO SMOKE POLLUTION; TUBULIN;

EID: 84861003588     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036752     Document Type: Article

References (59)

1. Anstey KJ, von SC, Salim A, O'Kearney R, (2007) Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 166: 367-378.
2. Ott A, Andersen K, Dewey ME, Letenneur L, Brayne C, et al. (2004) Effect of smoking on global cognitive function in nondemented elderly. Neurology 62: 920-924.
3. Cataldo JK, Prochaska JJ, Glantz SA, (2010) Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation. J Alzheimers Dis 19: 465-480.
4. Ott A, Slooter AJ, Hofman A, van HF, Witteman JC, et al. (1998) Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 351: 1840-1843.
5. Llewellyn DJ, Lang IA, Langa KM, Naughton F, Matthews FE, (2009) Exposure to secondhand smoke and cognitive impairment in non-smokers: national cross sectional study with cotinine measurement. BMJ 338: b462.
6. Barnes DE, Haight TJ, Mehta KM, Carlson MC, Kuller LH, et al. (2010) Secondhand smoke, vascular disease, and dementia incidence: findings from the cardiovascular health cognition study. Am J Epidemiol 171: 292-302.
7. Sabbagh MN, Tyas SL, Emery SC, Hansen LA, Alford MF, et al. (2005) Smoking affects the phenotype of Alzheimer disease. Neurology 64: 1301-1303.
8. Ulrich J, Johannson-Locher G, Seiler WO, Stahelin HB, (1997) Does smoking protect from Alzheimer's disease? Alzheimer-type changes in 301 unselected brains from patients with known smoking history. Acta Neuropathol 94: 450-454.
9. Tyas SL, White LR, Petrovitch H, Webster RG, Foley DJ, et al. (2003) Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study. Neurobiol Aging 24: 589-596.
10. Blennow K, Bogdanovic N, Alafuzoff I, Ekman R, Davidsson P, (1996) Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. J Neural Transm 103: 603-618.
11. Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, et al. (1998) Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 55: 326-335.
12. Lassmann H, Fischer P, Jellinger K, (1993) Synaptic pathology of Alzheimer's disease. Ann NY Acad Sci 695: 59-64.
13. Nicita-Mauro V, Lo BC, Mento A, Nicita-Mauro C, Maltese G, et al. (2008) Smoking, aging and the centenarians. Exp Gerontol 43: 95-101.
14. Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, et al. (2005) Obesity, cigarette smoking, and telomere length in women. Lancet 366: 662-664.
15. Rueff-Barroso CR, Trajano ET, Alves JN, Paiva RO, Lanzetti M, et al. (2010) Organ-related cigarette smoke-induced oxidative stress is strain-dependent. Med Sci Monit 16: BR218-BR226.
16. Bernhard D, Moser C, Backovic A, Wick G, (2007) Cigarette smoke-an aging accelerator? Exp Gerontol 42: 160-165.
17. Tuon T, Valvassori SS, Lopes-Borges J, Fries GR, Silva LA, et al. (2010) Effects of moderate exercise on cigarette smoke exposure-induced hippocampal oxidative stress values and neurological behaviors in mice. Neurosci Lett 475: 16-19.
18. Anbarasi K, Vani G, Balakrishna K, Devi CS, (2006) Effect of bacoside A on brain antioxidant status in cigarette smoke exposed rats. Life Sci 78: 1378-1384.
19. Liu X, Erikson C, Brun A, (1996) Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration. Dementia 7: 128-134.
20. Scheff SW, Price DA, Schmitt FA, Mufson EJ, (2006) Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 27: 1372-1384.
21. Heinonen O, Soininen H, Sorvari H, Kosunen O, Paljarvi L, et al. (1995) Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Neuroscience 64: 375-384.
22. Chow JY, Ma L, Cho CH, (1996) An experimental model for studying passive cigarette smoking effects on gastric ulceration. Life Sci 58: 2415-2422.
23. Chan KH, Ho SP, Yeung SC, So WH, Cho CH, et al. (2009) Chinese green tea ameliorates lung injury in cigarette smoke-exposed rats. Respir Med 103: 1746-1754.
24. Asami S, Hirano T, Yamaguchi R, Tomioka Y, Itoh H, et al. (1996) Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Cancer Res 56: 2546-2549.
25. Ozguner F, Koyu A, Cesur G, (2005) Active smoking causes oxidative stress and decreases blood melatonin levels. Toxicol Ind Health 21: 21-26.
26. Alberg A, (2002) The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 180, 121-137.
27. Kim SH, Kim JS, Shin HS, Keen CL, (2003) Influence of smoking on markers of oxidative stress and serum mineral concentrations in teenage girls in Korea. Nutrition 19: 240-243.
28. Sonnen JA, Larson EB, Gray SL, Wilson A, Kohama SG, et al. (2009) Free radical damage to cerebral cortex in Alzheimer's disease, microvascular brain injury, and smoking. Ann Neurol 65: 226-229.
29. Thome GR, Spanevello RM, Mazzanti A, Fiorenza AM, Duarte MM, et al. (2011) Vitamin E Decreased the Activity of Acetylcholinesterase and Level of Lipid Peroxidation in Brain of Rats Exposed to Aged and Diluted Sidestream Smoke. Nicotine Tob Res 13: 1210-1219.
30. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA, (1992) 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem 267: 166-172.
31. Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, et al. (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 19: 1959-1964.
32. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, et al. (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60: 759-767.
33. Isobe C, Abe T, Terayama Y, (2010) Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2′-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process. J Neurol 257: 399-404.
34. Fuller BF, Gold MS, Wang KK, Ottens AK, (2010) Effects of environmental tobacco smoke on adult rat brain biochemistry. J Mol Neurosci 41: 165-171.
35. Brody AL, Mandelkern MA, Jarvik ME, Lee GS, Smith EC, et al. (2004) Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol Psychiatry 55: 77-84.
36. Gallinat J, Meisenzahl E, Jacobsen LK, Kalus P, Bierbrauer J, et al. (2006) Smoking and structural brain deficits: a volumetric MR investigation. Eur J Neurosci 24: 1744-1750.
37. Pannese E, (2011) Morphological changes in nerve cells during normal aging. Brain Struct Funct 216: 85-89.
38. Edelmann L, Hanson PI, Chapman ER, Jahn R, (1995) Synaptobrevin binding to synaptophysin: a potential mechanism for controlling the exocytotic fusion machine. EMBO J 14: 224-231.
39. Greengard P, Valtorta F, Czernik AJ, Benfenati F, (1993) Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259: 780-785.
40. Hayashi K, Ishikawa R, Ye LH, He XL, Takata K, et al. (1996) Modulatory role of drebrin on the cytoskeleton within dendritic spines in the rat cerebral cortex. J Neurosci 16: 7161-7170.
41. Hayashi K, Shirao T, (1999) Change in the shape of dendritic spines caused by overexpression of drebrin in cultured cortical neurons. J Neurosci 19: 3918-3925.
42. Harigaya Y, Shoji M, Shirao T, Hirai S, (1996) Disappearance of actin-binding protein, drebrin, from hippocampal synapses in Alzheimer's disease. J Neurosci Res 43: 87-92.
43. Counts SE, Nadeem M, Lad SP, Wuu J, Mufson EJ, (2006) Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. J Neuropathol Exp Neurol 65: 592-601.
44. VanGuilder HD, Farley JA, Yan H, Van Kirk CA, Mitschelen M, et al. (2011) Hippocampal dysregulation of synaptic plasticity-associated proteins with age-related cognitive decline. Neurobiol Dis 43: 201-212.
45. Bulinski JC, (2007) Microtubule modification: acetylation speeds anterograde traffic flow. Curr Biol 17: R18-R20.
46. Hempen B, Brion JP, (1996) Reduction of acetylated alpha-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer's disease. J Neuropathol Exp Neurol 55: 964-972.
47. Querfurth HW, LaFerla FM, (2010) Alzheimer's disease. N Engl J Med 362: 329-344.
48. Wang JZ, Liu F, (2008) Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol 85, 148-175.
49. Saporito MS, Thomas BA, Scott RW, (2000) MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. J Neurochem 75: 1200-1208.
50. Tuerxun T, Numakawa T, Adachi N, Kumamaru E, Kitazawa H, et al. (2010) SA4503, a sigma-1 receptor agonist, prevents cultured cortical neurons from oxidative stress-induced cell death via suppression of MAPK pathway activation and glutamate receptor expression. Neurosci Lett 469: 303-308.
51. Su B, Wang X, Lee HG, Tabaton M, Perry G, et al. (2010) Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells. Neurosci Lett 468: 267-271.
52. Barr J, Sharma CS, Sarkar S, Wise K, Dong L, et al. (2007) Nicotine induces oxidative stress and activates nuclear transcription factor kappa B in rat mesencephalic cells. Mol Cell Biochem 297: 93-99.
53. Oddo S, Caccamo A, Green KN, Liang K, Tran L, et al. (2005) Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc Natl Acad Sci USA 102: 3046-3051.
54. Quiroz-Baez R, Rojas E, Arias C, (2009) Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of alpha-, beta- and gamma-secretase expression. Neurochem Int 55: 662-670.
55. Shen C, Chen Y, Liu H, Zhang K, Zhang T, et al. (2008) Hydrogen peroxide promotes Abeta production through JNK-dependent activation of gamma-secretase. J Biol Chem 283: 17721-17730.
56. Palop JJ, Mucke L, (2010) Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci 13: 812-818.
57. Lai CS, Preisler J, Baum L, Lee DH, Ng HK, et al. (2009) Low molecular weight Abeta induces collapse of endoplasmic reticulum. Mol Cell Neurosci 41: 32-43.
58. Henriques AG, Vieira SI, da Cruz E Silva EF, da Cruz E Silva OA, (2010) Abeta promotes Alzheimer's disease-like cytoskeleton abnormalities with consequences to APP processing in neurons. J Neurochem 113: 761-771.
59. Barnes DE, Yaffe K, (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10: 819-828.